WallStreetZenWallStreetZen

NASDAQ: SEEL
Seelos Therapeutics Inc Stock Ownership - Who owns Seelos Therapeutics?

OverviewForecastEarningsDividendOwnership

Insider buying vs selling

Have Seelos Therapeutics Inc insiders been buying or selling?
Buy
Sell
NameRoleDateSharesPriceValue
Michael Joseph GolembiewskiChief Financial Officer2024-02-29417$1.10
$457.45Buy
Raj MehraPresident Chief Executive Officer and Chairman of the Board of Directors2023-12-0175,757$1.32
$100.00kBuy
Michael Joseph GolembiewskiChief Financial Officer2023-11-3083,000$1.21
$100.26kBuy
Michael Joseph GolembiewskiChief Financial Officer2023-08-3112,500$0.62
$7.73kBuy

1 of 1

SEEL insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when SEEL insiders and whales buy or sell their stock.

SEEL Shareholders

What type of owners hold Seelos Therapeutics Inc stock?
Institutional
Insider
Retail
NameHoldSharesValueType
Alexander J. Denner116.42%15,926,959$5.29MInsider
Southpoint Capital Advisors LP100.11%13,695,524$4.55MInsider
Armistice Capital LLC67.25%9,200,000$3.05MInsider
Jacob May48.85%6,682,640$2.22MInsider
Y. Joseph Mo14.30%1,956,429$649.53kInsider
Bassam Damaj14.17%1,938,087$643.44kInsider
Henry Jemil Esber7.78%1,064,757$353.50kInsider
Mark Westgate6.43%879,318$291.93kInsider
Kleanthis G. Xanthopoulos2.97%406,615$135.00kInsider
Arthur D. Emil2.40%328,579$109.09kInsider

1 of 3

SEEL vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
SEEL3.20%96.80%Net BuyingNet Buying
SNGX0.36%99.64%
TCBP0.12%11.35%
NEXI1.34%98.66%Net Selling
VRPX4.26%95.74%
View Top Biotech Stocks

Seelos Therapeutics Stock Ownership FAQ

Who owns Seelos Therapeutics?

Seelos Therapeutics (NASDAQ: SEEL) is owned by 13.05% institutional shareholders, 394.81% Seelos Therapeutics insiders, and 0.00% retail investors. Alexander J. Denner is the largest individual Seelos Therapeutics shareholder, owning 15.93M shares representing 116.42% of the company. Alexander J. Denner's Seelos Therapeutics shares are currently valued at $5.38M.

If you're new to stock investing, here's how to buy Seelos Therapeutics stock.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.